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ABSTRACT

Older adults are among the fastest-growing segment of the world’s population. In
Costa Rica, life expectancy is comparable to developed countries, such as the United
States and Western European countries. The loss of cognitive capacity is one of the most
significant issues affecting the quality of life of older adults and their families. Although
the causes of cognitive decline remain uncertain, it has been linked to cardiovascular risk
factors such as diabetes mellitus and high blood pressure. Dietary fatty acids have an
important role in these conditions, making it is plausible that they could play a role in
cognitive deterioration
The purpose of this research is to examine the association among fatty acid intake,
lipid profile, and cognitive health in Costa Rican elders. To examine these issues, a crosssectional secondary data analysis was performed using public data from the Costa Rican
Longevity and Healthy Aging Study, a nationally representative longitudinal survey of
health and socioeconomic indicators of Costa Rican residents ages 60 and over in 2005
(n=2878). All data and specimens in the study were collected at the participants’ homes,
usually during two visits. Diet information was collected using a semi-quantitative food
frequency questionnaire. Cognitive disability was assessed with an adaptation of the
Mini-Mental State Examination (MMSE). Participants who answered the 15 items with
fewer than 75% correct answers were considered to be ―cognitively impaired.‖ Serum
lipid analyses were conducted by nationally certified laboratories. General characteristics
between cognitively disabled and non-cognitively disabled participants were explored
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using descriptive statistics. Regression models were controlled for age, caloric intake, and
lipid medication.
The study found highly significant differences between cognitively disabled and
non-cognitively disabled older adults. The demographic data indicated that adults with
less than 75% accuracy on the MMSE were younger, had lower monthly income, and had
completed fewer years of formal education. Important differences were also found in the
health profile. Medical diagnoses of diabetes, stroke, and heart attack were significantly
higher among the cognitively disabled. Non-cognitively disabled adults had a higher rate
of medical diagnosis of dyslipidemia and presented a higher rate of metabolic syndrome.
Anthropometric data confirmed that cognitively disabled elders had a lower BMI, lower
body weight, and higher percentage of underweight. The dietary analysis revealed a
lower energy, total fat, and monounsaturated fatty acids intake compared to their
counterparts. The lipid profile from adults who were not cognitively disabled indicated
significantly higher levels of LDL, triacylglycerides, and total cholesterol. The multiple
regression analysis suggested a significant (p<.050), yet weak (R2=.299), association
between MMSE score and serum lipid profile as well as dietary fatty acids.
Differences in Costa Rican elders’ demographic, health, and diet characteristics
were found between cognitively disabled individuals and those not disabled. Dietary fat
intake and serum lipid profile were weakly associated with cognitive outcomes. Further
research, particularly longitudinal studies, are needed to better examine this relationship.
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CHAPTER ONE
INTRODUCTION

Older adults are among the fastest growing segments of the world population. The
number and proportion of this population is increasing in both developing and developed
countries; by 2015 people aged 65 or older will outnumber children under the age of five
(World Health Organization, National Institute of Aging & National Institute of Health,
2011). Currently, in the entire world population, one out of every ten persons is over 60
years old (United Nations Population Fund, 2010). By 2025, the proportion of older
adults is expected to reach 25% in North America, 21% in Eastern Asia, 14% in Latin
America and 11% in South and Central Asia (United Nations Population Division,
2001).The majority of older people over the age of 60 years now live in developing
countries, where the most rapid demographic changes are occurring, with predicted
increases of 200-400 percent in their older populations during the next decades (WHO,
2000).
Mortality rates have declined due to improvement in social development, living
standards, hygiene, sanitation and infectious disease prevention (United Nations
Population Division, 2001). Life expectancy in the U.S. has increased from 47 years, for
Americans born in 1900, to 77 years, for those born in 2001 (Centers for Disease Control
and Prevention & The Merck Company Foundation, 2007). Recent data, establishes a life
expectancy of 76 years for males and 81 years for females (CDC & National Center for
Health Statistics, 2011). In low income countries, life expectancy has increased from 45
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years in the 1950s to 64 years in the 1960s (UNPD, 2001). Additionally, fertility rates
have fallen all over the world, mainly due to the development of effective contraceptive
methods and improvements in women’s education (WHO, 2000).
Increases in longevity and the proportion of people over the age of 60 years, is
often regarded as a challenge to health systems as longer lives are commonly associated
with a prevalence of disease (WHO, 2000). The leading causes of death have shifted
dramatically from infectious diseases to non-communicable, chronic diseases and from
younger to older individuals (UNPD, 2001). Disabilities associated with chronic illness
also increase with advancing age (CDC, 2011).
The medical conditions most frequently encountered in this age group include
cardiovascular disease, osteoarthritis, osteoporosis, depression, diabetes, sensory deficits,
cognitive decline, and dementia (CDC & The Merck Company Foundation, 2007). The
loss of cognitive capacity is one of the most important factors affecting the quality of life
of older adults and their families and it is one of the main reasons that people are
admitted into nursing homes (Gaugler, Duval, Anderson & Kane, 2007).
Most experts agree that the components of healthy cognitive function include
language, thought, memory, executive function (the ability to plan and carry out tasks),
judgment, attention, perception, remembered skills (such as driving) and the ability to
live a purposeful life (National Research Council, 2000). Cognitive health is not limited
to the absence of disease, it can range from optimal functioning, slight cognitive
impairment, to severe dementia (Hendrie et al., 2006).
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As the population ages, it is important to understand the influence of modifiable
lifestyle factors such as diet on lifespan, as well as ―healthspan‖, including cognitive,
mental and physical health maintenance into advanced age. The causes of cognitive
decline remain uncertain; however they have been linked to cardiovascular disease and
cardiovascular risk factors such as diabetes mellitus and high blood pressure (Naqvi et
al., 2011).
Dietary fatty acids have an important role in cardiovascular disease, thus it is
plausible that they could have a role in cognitive deterioration (Hunter, Zhang & KrisEtherton, 2009). Fatty acids could be involved through several mechanisms; including
atherosclerosis, thrombosis, and inflammation (Kalmijn, 2000).
There has been increasing interest in the hypothesis that fish consumption,
polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA) could play a protective role against cognitive decline. However, evidence of
this relationship remains controversial. Results are also inconsistent in large crosssectional studies focused on dietary intake, particularly fish and marine PUFA. Findings
from longitudinal data are less controversial; but still disputed (Carpurso et al., 2003;
Morris et al., 2004). Several studies suggested that an increase of saturated fats could
have negative effects on cognitive health (Kalmijn, Feskens, Launer & Kromhout, 1997;
Freeman, Haley-Zitlin, Stevens & Granholm, 2011) while PUFA and monounsaturated
fatty acids (MUFA) may have a protective effect (Capurso et al., 2003; Solfrizzi et al.,
1999). Except for reports from an ongoing Chilean study (Hirsch, de la Maza, Barrera,
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Gattas, Petermann & Bunout, 2002), there are no known studies on this topic in Latin
American countries or developing nations.

1.1 Statement of Purpose
The aim of this research is to determine the association between diet, serum lipids
and cognitive health in older adults.

1.2 Research Questions
This thesis will explore two research questions and hypotheses on the relationship
of diet and nutrition to cognitive health by using secondary cross-sectional data from a
population of Costa Rican older adults.

1. What is the relationship between fatty acid intake and cognitive health in Costa
Rican elders?
Hypothesis (H1): PUFA, particularly n-3 and n-6, will have a protective effect on
cognitive health.

2. Is there an association between serum lipid profile and cognitive health in Costa
Rican elders?
Hypothesis (H2): A desirable serum lipid profile will have a protective effect on
cognitive health.
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CHAPTER TWO
LITERATURE REVIEW

The average life expectancy in Costa Rica is 79 years: 77 years for men and 81
years for women (World Health Organization, 2009). This is the highest life expectancy
in Latin America. When compared to life expectancy in the region the gap is even
broader: Central American countries report a life expectancy ranging from 69 years in
Guatemala and El Salvador to 74 years in Panama. Costa Rican life expectancy is
comparable to that of developed countries such as the United States and Western
European countries. In addition, compared to adult men over 60 years old, Costa Rican
males have a longer life expectancy than white males in the United Stated (BrenesCamacho & Rosero-Bixby, 2009; Rosero-Bixby, 1995). For men over 90 years old, life
expectancy is one-half year more in Costa Rica than in any other country (Rosero-Bixby,
2008). Comparisons with the United States and Sweden show that the Costa Rican
advantage comes mostly from a reduced incidence of cardiovascular diseases, coupled
with a low prevalence of obesity (Rosero-Bixby & Dow, 2009). Of added importance to
this comparison, is the fact that the Costa Rican Gross National Product is a small
fraction of the Gross National Product for the United States or Western European
countries (United Nations, 2009a).
The Costa Rican Social Security system is one important factor for the Costa
Rican high life expectancy (de Bertodano, 2003; Rosero-Bixby, 2004a). While private
health care is available, most health services since 1941 have been provided by the Costa
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Rican social security system, known as Caja Costarricense del Seguro Social (CCSS).
This system is funded from individual payroll deductions, contributions from the
employers, and the government. Those who contribute to the CCSS are entitled to health
insurance that allows them and their family to receive free health care services and
medications at any public hospital, clinic or community health (Brenes-Camacho &
Rosero-Bixby, 2008). The CCSS covers about 90% of the population including 9% of the
individuals whose insurance is paid by the government. These percentages are higher
among the elderly where 95% are covered and up to 22% have voluntary governmentcovered insurance (Rosero-Bixby, 2004b). People who consistently declare themselves as
uninsured (10% of total population, 5% of the elderly) can still obtain health care from
the CCSS units for a fee or for free if institutional social workers verify that the patients
have no means to pay for health care services (de Bertodano, 2003).
Analyses of data from developed countries have found socioeconomic status
(SES) and adult health to be significantly positively correlated with better health at higher
SES (Seeman, Merkin, Crimmins, Koretz, Charette, & Karlamangla, 2008). Differences
in SES and use of preventive health care services in older adults have also revealed SES
disparities in health service utilization. People with higher SES were more likely to take
advantage of most preventive services and utilization rates among uninsured seniors were
lower than among their insured peers (Brenes-Camacho & Rosero-Bibxy, 2009). In
contrast, research on both mortality and metabolic syndrome among Costa Ricans reveals
that those who are better educated and wealthier are worse than those with lower SES
strata. Nevertheless, quality-of-life related measures such as functional and cognitive
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disabilities, physical frailty, and depression all clearly worsen with lower SES (RoseroBixby & Dow, 2009).
In some developed countries, an association of lower educational attainment with
greater risk of mortality has been found (Kunitz, 2007) although in Costa Rica there are
relatively minor associations between mortality and education among those aged 60 and
above (Rosero-Bixby, Dow & Lacle, 2005). In contrast, a recent analysis in the United
States of similarly aged individuals revealed substantial differentials by education, with
mortality rates 5-6% higher per year for each year less of education (Steenland, Henley &
Thun, 2002). To explore this association, data from older adults participating in National
Health and Nutrition Examination Survey (NHANES) was compared to data from the
Costa Rican Longevity and Healthy Aging Study (CRELES, or Costa Rica Estudio de
Longevidad y Envejecimiento Saludable). Results indicate significantly lower hazardous
levels of risk biomarkers at higher levels of education for more than half of the risk
factors in the United States as compared with less than a third of the outcomes in Costa
Rica (Rehkopf, Dow & Rosero-Bixby, 2009).
To determine the relationship between socialized health care and longevity,
research has been conducted to explore the relationship between longevity and chronic
disease management by both CCSS and private health care. In one study, the metabolic
control of diabetes in community health care centers, regional clinics and hospitals, and a
subsample of 542 CRELES participants with self-reported diabetes mellitus was
assessed. Except for elevated levels of triacylglycerides and low density lipoproteins
(LDL) in patients from community health centers, no statistical differences in the other

9

metabolic control indicators were seen across health care settings (Brenes-Camacho &
Rosero-Bixby, 2008). Levels of metabolic control among elderly people with diabetes
mellitus were found to be similar to those observed in industrialized countries (BrenesCamacho & Rosero-Bixby, 2008).
A similar study of Costa Rican older adults, from this same data set, examined the
prevalence, hypertension unawareness and treatment by demographic variables and found
gender differences in prevalence, condition unawareness, and treatment with odds of
being treated higher in educated individuals (Mendez-Chacon, Santamaria-Ulloa &
Rosero-Bixby, 2008).

2.1 Allostatic Load
A framework which has gained popularity in the study of ageing and longevity is
the allostatic load. Allostasis means ―maintaining stability (or homeostasis) through
change‖; the concept was proposed by McEwen and Stellar (1993) to refer to wear and
tear on the body. The allostatic load suggests that resting levels of the neuroendocrine
markers become dysregulated through stress experienced over time.
The two main hypotheses established related to this subject, are that allostatic
load is a measure of physiological dysregulation; and that allostatic load is a risk factor
for morbidity and mortality (Seeman, Singer, Rowe, Horwitz, & McEwen, 1997). Both
theories have been examined when looking at the unusually high longevity in Costa Rica.
Results from this analysis were contrary to these hypotheses, since stressors were not
associated with individual biomarker levels and levels of neuroendocrine allostatic
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indicators (cortisol dehydroepiandrosterone sulfate, epinephrine, and norepinephrine)
(Gersten, Dow & Rosero-Bixby, 2010).
There are some relatively new findings about the differentials and determinants of
aging and longevity, particularly in developing countries. Although research on the
impact of diet and supplementation in aging and longevity has been conducted in
developed nations, little is known about the populations from developing countries.

2.2 Cardiovascular Disease and Fatty Acids
In 2008, chronic diseases accounted for 63% of the 57 million estimated deaths
worldwide (WHO, 2010). In Costa Rica, during the 1970s, health indicators such life
expectancy, infant mortality, health coverage and sanitation showed a noteworthy
improvement (Rosero-Bixby, 1996). Death rates from infectious diseases declined
sharply and rates of mortality from cardiovascular disease increased. Since then,
cardiovascular disease, particularly myocardial infarction became the leading cause of
deaths among Costa Rican adults (Rosello-Araya & Guzman-Padilla, 2004). Since the
leading causes of death are linked to diet and other modifiable risk factors it is logical to
think that these play a decisive role in aging and longevity.
Lipids are organic compounds that are insoluble in water and soluble in organic
substances such as ether, acetone and chloroform (Jones & Kubow, 1998). They are
important constituents of the diet due to their high energy value (9 kcal/g), but also
because fat soluble vitamins and essential fatty acids are natural components of foods
(Gurr, Harwood & Frayn, 2002).
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Fats, a subgroup of lipids, are carboxylic esters derived from a single alcohol,
glycerol, to which three fatty acids are attached. More specifically, the molecule is called
triacylglycerol. Fatty acids linked to the glycerol portion of the triacylglycerol may vary
in length of the carbon chain, degree of saturation and the spatial configuration (Gurr et
al., 2002).
Fatty acids may be long-chain monocarboxylic acids. They usually contain an
even number of carbon atoms, usually between 12 and 24. The chemical properties of
fatty acids are derived from the coexistence of a carboxyl group and a hydrocarbon chain
(Gurr et al., 2002).When all the hydrogen atoms of a fatty acid are bonded to carbon
atoms, it is saturated. In turn, a fatty acids is unsaturated when there are one or more
double bonds between carbon atoms, thus decreasing the number of hydrogen atoms that
are bound (Jones & Kubow, 1998).
Double bonds between carbon atoms of an unsaturated fatty acid may have
different configurations depending on the spatial orientation of the hydrogen atoms
bonds. These configurations are called cis or trans, depending on whether the two
hydrogen atoms are oriented in the same (cis) or in the opposite direction (trans) to the
plane as defined by the double bond between carbons (Jones & Kubows, 1998).
Usually, in nature, the unsaturated fatty acid is cis oriented. This means the
provision of the molecule is angled, with the vertex at the unsaturation. This spatial
configuration causes the melting points of the unsaturated acids to be lower than the
saturated counterparts. In contrast, the double bonds in the trans fatty acids (TFA) distort
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the crystal symmetry, making it very similar to the saturated fatty acids and increasing its
melting point (Gurr et al., 2002).
Some fatty acids cannot be synthesized by higher animals (including humans),
and because its biological function is essential, it must be supplied in the diet. For this
reason they are called essential fatty acids (Gurr et al., 2002). The consumption of an
adequate intake of fatty acids, in addition to meeting the needs of energy and essential
fatty acids helps to reduce the risk of cardiovascular disease. In the 1970s, the classic
diet-heart hypothesis was proposed to explain the relationship between diet and
cardiovascular disease risk (Hu & Willet, 2001).

2.2.1 n-6 Polyunsaturated fatty acids (n-6 PUFA)
The classic studies of Keys, Anderson and Grande (1965) and Hegsted,
McGandy, Myers and Stare (1965) indicated that the both polyunsaturated and
monounsaturated fatty acids had a neutral effect on serum cholesterol levels. However,
current evidence has shown otherwise, corroborated by metabolic studies that n-6 PUFA
decrease serum cholesterol (Ascherio, 2002). A compilation of several metabolic studies
showed that vegetable oils, rich in linolenic acid (primary n-6 PUFA), have a strong
cholesterol-lowering effect when they replace saturated fatty acids (SFA) it in the diet
(Grundy et al., 1982). This coincides with the results of dietary intervention trials which
showed that diets high in n-6 PUFA (17% energy intake), compared with diets low in fat
(<30% energy intake) and high in carbohydrates (>60% energy intake), are more
effective in lowering serum cholesterol levels and mortality rates of cardiovascular
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disease (Sacks & Katan, 2002). Similarly, prospective cohort studies have shown an
inverse association between intake of linoleic acid and risk of coronary heart disease (Hu,
Mason & Willet, 2001).
In addition to its effect on serum cholesterol, linoleic acid appears to have other
beneficial effects on cardiovascular disease. In the Nurses' Health Study (Salmeron et al.,
2001), a high consumption of marine n-6 PUFA was associated with a significantly lower
incidences of type 2 diabetes, as this may improve sensitivity to insulin. Additionally,
animal studies have suggested an antiarrhythmic effect from sunflower oil, which is rich
in linoleic acid, although it is less than the effect generated by fish oil (Hu et al., 2001).
Other studies have shown that the addition of a high amount of linoleic acid to a
diet low in SFA lowers serum cholesterol levels by 15% which significantly reduces the
risk of cardiovascular disease. Many controlled trials have shown that a 1% reduction in
total serum cholesterol and LDL causes a decrease of about 1.5% in the incidence of
cardiovascular disease (Renaud & Lanzmann-Petithory, 2001).
In response to the considerable scientific evidence showing the strong cholesterollowering effect of linolenic acid, dietary recommendations in the 1970s and 1980s
strongly encouraged the consumption of this fatty acid. However, subsequent studies
showed that an intake of linolenic acid greater than 10% of total energy intake, reduced
concentrations of high density lipoprotein (HDL) (Rubio, 2002) leading to a

pro-

thrombotic and pro-aggregatory physiological state, characterized by increased blood
viscosity, vasospasm, vasoconstriction and reduced bleeding time (Simopoulos, 1999).
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2.2.2 n-3 Polyunsaturated fatty acids (n-3 PUFA)
Of the n-3 PUFA, α-linolenic acid (C18:3n-3) is the most abundant in the diet and
is found mainly in linseed oil (51%), canola (9%) and flaxseed oil, walnut oil and
soybean (7%). It is also found in small amounts in nuts, dairy products, beans, broccoli
and green leafy vegetables (Rubio, 2002).
The n-3 PUFA long-chain Eicosapentaenoic acid (EPA) (C20:5n-3) and
Docosahexaenoic acid (DHA) (C22:6n-3) are found in small amounts in the diet coming
mainly from high-fat fish such as mackerel (2.5%), salmon (1.2%), sardines (1.2%), tuna
(0.4%) and halibut (0.4%), although it may be synthesized in humans from α-linolenic
acid (Simopoulus, 1991).
Several epidemiological studies have examined the association between
consumption of n-3 PUFA and risk of cardiovascular disease. In the Multiple
Intervention Trial Risk Factors, men in the highest quintile of α-linolenic acid
consumption showed a risk of cardiovascular disease 40% lower than in men in the lower
quintiles of consumption (Dolecek, 1992). This coincides with the results of the Study of
Health Professionals Follow-up (Ascherio et al., 1996) which associated a 1% increase in
the consumption of α-linolenic acid acid with 40% lower risk of fatal cardiovascular
disease. Likewise, the Finnish Study for Cancer Prevention with Alpha Tocopherol and
Beta Carotene, revealed that men in higher quintiles of consumption of α-linolenic acid
had 25% reduction in cardiovascular disease mortality (Pietinen et al., 1997).
In Costa Rica, Baylin, Kabagambe, Ascherio, Spiegelman and Campos (2003)
showed an inverse association between levels of α-linolenic acid in adipose tissue and
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nonfatal myocardial infarction. The risk of myocardial infarction was 63% lower in those
subjects in the highest quintile of linoleic in adipose tissue than those in the lowest
quintile. Additional population studies have demonstrated the protective effect of αlinolenic acid in the prevention of myocardial infarction (Ascherio et al., 1996; Djousse
et al., 2004; Guallar et al., 1999) whereas other studies have found an increased risk from
the intake of α-linolenic acid acid (Oomen et al., 2001a; Pedersen et al., 2000).
One possible explanation for these results is that α-linolenic acid and TFA come
from similar sources, so it is difficult to distinguish their antagonistic effect. In the
Cancer Prevention Study with Alpha Tocopherol and Beta Carotene, a clear association
was evident only after adjustments for the intake of TFA (Pientinen et al., 1997). In
addition, the association reported by Baylin et al (2003), was strengthened after
adjustments for these fatty acids. Another viable explanation is that the cardioprotective
effect of α-linolenic acid is higher in places like Costa Rica, where there is less
consumption of fish species rich in EPA and DHA (Baylin et al., 2003).
The protective effect of α-linolenic acid can be achieved by direct action or
mediated by its conversion to EPA and DHA (Connor, 2002). The mechanism of action is
unclear, but among the potential biological effects are the reduction of plasma levels of
triglyacylcerides and Very Low Density Lipoprotein (VLDL) in both normal subjects and
those with hypertriglyceridemia, although the effect is higher in the latter (Djousse et al.,
2004; Connor, 2002). Similarly, one of the most noticeable effects of n-3 PUFA, is the
ability to prevent cardiac arrhythmias by the modulation of sodium, potassium, and Ltype calcium channels, inhibition of thromboxane production and by reducing the
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concentration of non-esterified fatty acids in plasma and cell membranes which are
believed to have pro-arrhythmic effects (Albert et al., 2002).

2.2.3 n-6 and-3 PUFA Ratio
In Western diets, high intake of n-6 PUFA has created an imbalance, with respect
to the intake of n-3 PUFA, to the extent that the relationship of n-6:n-3 in Western diets
ranges between 15-20: 1. It has been suggested that diets should maintain a relationship
between the intake of n-6 and n-3 PUFAs of 4:1 or less. Both n-6 and n-3 are primary
components in the production of eicosanoids. There is a competition among the two
families of fatty acids for the enzymes involved in the conversion of α-linolenic acid and
linolenic acid to EPA (Renaud & Lanzmann-Petithory, 2001; Simopoulus, 1999). In the
Nurse’s Health Study it was evident that there was a modest reduction in cardiovascular
disease risk when the ratio of α-linolenic acid to linolenic acid was greater than 0.10
(1:10) (Hu et al., 2001).
To improve the n-6/n-3 ratio some have proposed to promote the reduction of n-6
PUFAs. However, considering the significant cardio protective effect of them, the most
viable solution seems to be replacing animal fat with vegetable oils, which contain
both poly and monounsaturated fatty acids (Hu et al., 2001). This replacement can also
increase consumption of n-3 PUFA, for various oils including canola and soybean have a
significant content of ALA (Connor, 2002). Moreover, the consumption of at least two
servings of fish per week may increase the amount of n-3 in the diet to achieve a ratio of
n-3: n-6 without sacrificing desirable benefit of n-6 PUFA (Hu et al., 2001).
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2.2.4 Trans Fatty Acids (TFA)
Oils rich in α-linolenic acid and linolenic acid, because of their susceptibility to
oxidation, are often hydrogenated during processing, making the cis fatty acids in TFA.
Functionally, these fatty acids act as SFA making fat more solid and stable at room
temperature, but have been positively associated with the development of cardiovascular
disease (Willet, 1998).
The replacement of cis oriented unsaturated fatty acids with TFA has been linked
to increased levels of LDL and decreased levels of HDL (Ascherio, Katan, Zock,
Stampfer & Willet, 1999). It has been proposed that TFA has a negative impact on the
LDL/HDL ratio is approximately twice as much as SFA; an increase of 2% TFA
consumption may boost the ratio of LDL/HDL by 0.1 (Ascherio et al., 1999). A 1-unit
increase in this ratio is associated with a 53% increase in the risk of cardiovascular
disease (Stampfer, Sacks, Salvini, Willet & Henneckens, 1991), so the average
consumption of 2% of calories derived from TFA could be a predictor of a high number
of deaths from this disease (Ascherio et al., 1999).
Dietary TFAs also increases serum triacylglycerols, LDL and liprotein levels
while decreasing HDL (Hu et al., 2001; Sundram, Ismal, Hays, Jeyamalar &
Pathmanatan, 1997). Meanwhile, Kyung and Campos (2003) have suggested that the
effect of the intake of TFA on cardiovascular disease risk may be mediated by the effect
of these fatty acids on LDL size. They found a significant correlation between increased
intake of TFA and increased LDL size. The large LDL has high affinity for arterial
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proteinglycans (Manning et al., 1994). Cell cholesterol particles are released to the
connective tissue of the arterial wall (Rudel, Parko, Hedrick, Thomas & Williford, 1998).
Increased TFA may increase the risk of thrombosis, as these are capable of
adversely affecting metabolism and the balance of prostanoids, in competing for the
enzyme Δ6 desaturase with linoleic and α-linolenic acid (Hu & Willett, 2001) . Likewise,
it is suggested that the high uptake of TFA promotes insulin resistance in humans
(Lovejoy, 1999). Research on TFA mechanisms reveals inconsistencies, however results
from animal studies suggest that post-insulin receptor activation of insulin-stimulated
serine/threonine protein kinase is impaired in muscle tissue from monkeys fed a highTFA diet (Kavanagh et al., 2007).
The strongest evidence of the association between TFA consumption and
cardiovascular risk, comes from four prospective studies: the Health Professionals
Follow-up Study, the Alpha-Tocopherol and Beta-Carotene Cancer Prevention Study,
Nurses’ Health Study and the Zutphen Aging Study. In these, the relative risk of
cardiovascular disease associated with an absolute increase of 2% of energy from TFA,
ranged from 1.28 (Oomen et al., 2001b) to 1.93 (Hu et al., 1999).
In the Nurses’ Health Study, replacing 5% of energy from PUFAs with SFA was
associated with reduced risk of cardiovascular disease of 42%. However, replacing 2% of
the energy derived from TFA with PUFA was associated with a reduction of 53% (Hu et
al., 1999). In this study, each increase of 2% of total calories as TFA was associated with
a 39% increase in the risk of Type 2 Diabetes Mellitus.
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In Costa Ricans, a positive association between TFA 18:2 in adipose tissue and
risk of nonfatal myocardial infarction has been shown. In addition, a positive association
of 16:1 between trans isomer levels and risk of nonfatal myocardial infarctions was
found (Baylin et al., 2003).
Baylin and colleagues (2003) also suggested that the 18:2 trans isomer may be
more atherogenic than the 18:1 trans, although the first one is found more abundantly in
the diet and adipose tissue. Lemaitre and colleagues (2002) have also reported a strong
positive association between levels of 18:2 trans isomer in the membrane of red blood
cells and risk of acute myocardial infarction.
In addition, clinical trials have shown that the trans 18:1 isomer adversely affect
the lipoprotein profile (Hu et al., 2001) and have recently reported that patients with
cardiovascular disease have a higher concentration of this isomer in the subcutaneous fat
tissue (Dlouhy et al., 2003). However, epidemiological studies in Costa Rica (Baylin et
al., 2003) and elsewhere (Aro et al., 1995) have found no association between levels of
18:1 trans isomer in adipose tissue and risk of myocardial infarction.
In Costa Rican households, palm butter, margarine, dairy products and
confectionery were the main sources of SFA in the diet of adolescents. Partially
hydrogenated soybean oil was the main source of TFA, providing 34% of the total, while
about 35% came from natural sources such as meat and dairy products. The rest was
contributed by TFA palm butter, margarine, baked goods and others (Monge-Rojas,
Campos & Fernández, 2005).
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Compared to TFA of industrial origin, the effect of TFA of ruminant origin on
cardiovascular disease risk is less clear. Experimental studies suggest that the latter may
have an adverse effect on the lipid profile when consumed in amounts similar to those of
industrial origin TFA (Mozzafarian & Willet, 2008). In contrast, epidemiological studies
have found positive associations between TFA of ruminant origin and cardiovascular
disease which is probably due to the fact that the levels of natural TFA consumption are
relatively low. Additionally, there are differences between the natural and industrial
isomers (Mozafarian, 2008).

2.3 Dietary Guidelines and Fat Intake
Despite the lack of evidence that diets high in fat promote cardiovascular disease,
most dietary recommendations have aimed at reducing total fat rather than fat quality
(Erkkila, de Mello, Riseus & Laaksonen, 2008). More recent recommendations, including
the Dietary Guidelines for Americans 2010 include within its key recommendation the
reduction of SFA to less than 10% of total energy intake, replacing them with MUFA and
PUFA. In addition, TFA intake is recommended to be as low as possible, especially if the
TFA comes from synthetic sources, to use oils to replace solid fats, and to increase
consumption of low fat dairy products and fish (United States Department of Agriculture
& United Stated Department of Health and Human Services, 2010).
The Third Report of the National Cholesterol Education Program, Expert Panel on
Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III) recommend the Therapeutic Lifestyle Changes Diet which includes
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weight loss and physical activity and dietary modifications addressing both fat intake
quantity and quality (National Institute of Health; National Heart, Lung and Blood
Institute, 2002). Recommendations include:


A total fat intake of 25-35% total energy intake



PUFA up to 10% of total energy intake



MUFA up to 20% of total energy intake



SFA less than 7% of total energy intake

These guidelines do not include specific recommendations for TFA, establishing
they have a LDL increasing effect and should be kept at low intake. N-3 PUFA are
included as an optional recommendation; however, fish intake is encouraged. Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel
IV) guidelines are currently under review and are expected to be released in 2012
(Grundy et al., 2011).
The dietary guidelines for Costa Rica suggest that only 25% of the total energy
should come from fat (Ministerio de Salud, 1997), however the recommendations of the
National Academy of Sciences and the Food and Nutrition Board (2005), and the Institute
of Nutrition of Central America and Panama (1994) established as appropriate a range of
25 to 30%. Recent studies indicate that most Costa Ricans usually have a fat intake less
than or equal to 30%, which is supported by the results of nutrition surveys, revealing
that only 35% in 1996 and 29% in 2001 of Costa Rican households exceeded the
recommended fat intake (Ulate, 2006).
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As a strategy to promote cardiovascular health in childhood and adolescence, and
to prevent the development of cardiovascular disease in adulthood, the Committee on
Atherosclerosis, Hypertension and Obesity in Youth of the American Heart Association
(Williams et al., 2002) has emphasized the need to establish a diet low in saturated fat at
an early age. The recommendations made by the committee included:


The total fat should provide no more than 30% or less than 20% of energy
intake.



The SFA should provide less than 10% of energy intake.



PUFA should provide up to 10% of energy intake.



MUFA should provide 10-15% of energy intake.

There are no officially recognized recommendations for the intake of specific
fatty acids. The Working Group on the Recommended Dietary Intakes (RDIs) for
Essentiality of Fatty Acids, Omega-6 and Omega-3 has proposed recommendations for
adults. The suggested adequate intake of linoleic acid is 2 % of total energy consumption
and an upper limit of 3% (Simopoulos, 1999). Additionally, they suggested an adequate
intake of α-linolenic acid corresponding to 1% of daily energy intake.

2.4 Fatty Acids, Chronic Disease and Cognitive Health
In order to understand the mechanisms by which fatty acids affect the risk of
cognitive health decline in older adults, it is imperative to understand the
pathophysiology of atherosclerosis. Many diseases are capable of producing circulation
disorders in the coronary vessels and in cerebral and peripheral arteries. The most
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common of these is atherosclerosis. This is a multifactorial disease that develops
chronically before becoming clinically symptomatic. The consequences of this disease
are coronary disease, stroke and occlusive disease of the peripheral arteries (Stary et al.,
1995).
Various theories have been proposed to explain the pathogenesis of
atherosclerosis, which include the theory of response to injury (Ross, 1993), the theory of
modified lipoproteins (Steinberg & Witztum, 1990), the theory of retention of LDL
(Williams & Tabas, 1995) and the immune hypothesis (Wick et al., 1997). A combination
of these theories reveals four factors involved in the pathogenesis: the vascular
endothelium, LDL, macrophages and smooth muscle cells. They participate in an
excessive inflammatory fibro-proliferative endothelium and smooth muscle arterial wall
injury (Moreno & Mitjavila, 2003). This results in a hardening and narrowing of the
arterial intima, which may partially or completely block blood flow, causing, depending
on the affected area, heart attack, gangrene, kidney failure, and other disease states
(Moreno & Mitjavila, 2003).
These four hypotheses refer to an alteration in lipid profile as the main trigger of
atherosclerotic plaque development. This plaque evolved chronically and silently,
narrowing the arteries and leading to the development of vascular disease. Currently,
scientific evidence has changed this view and notes that the influence of fatty acids in the
development of chronic disease beyond the hypercholesterolemic effect. The fatty acid
intake may affect thrombotic tendencies, heart rate, endothelial function, systemic
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inflammation, insulin sensitivity and oxidative stress (Hu & Willett, 2001); all of which
have been linked to longevity and cognitive function.
There is a strong relationship between increasing age and high blood pressure.
Normal aging produces an increase in systolic blood pressure due to decreased artery
elasticity because of the thinning and fragmentation of vascular elastin and the collagen
deposition (Copstead & Banasik, 2006; Rosendorff et al., 2007). Until about 50 years of
age, both systolic and diastolic blood pressure rise. After this, systolic blood pressure
continues to rise; diastolic blood pressure tends to fall (Vasan et al., 2002). There is also
epidemiological data that suggests an inversely proportional relationship between age of
hypertension diagnosis and cardiovascular risk (National Research Council, 2000).

2.4.1 Dietary Fatty Acids and Cognitive Health
The causes of cognitive impairment are unknown. There are some studies on the
role of the diet in cognitive decline in older adults (Vizuete, Robles, RodriguezRodriguez, Lopez-Sobaler & Ortega, 2010). Recent studies have suggested that dietary
fatty acids may play a role in the development of cognitive decline associated with aging
or dementia (Solfrizzi et al., 2005; van de Rest et al., 2009).
One of the first studies was a population-based study conducted in France by
Pradignac et al. The association among macronutrient intake and cognitive function was
studied in 226 men and 215 women, aged 65 or more, free living and in good health. A
positive relationship between fatty acid intake and the Mini Mental State Examination
(MMSE) was found in women. In men, alcohol and PUFA intake was associated with an

25

improvement in functional and cognitive parameters. PUFA intake was also related to
mobility in men. However, this study had a low response rate and these findings may be
explained as indicators of better health status (Pradignac, Schlienger, Velten, & Mejean,
1995).
A similar study from Spain assessed the association between dietary intake and
global cognitive functions using the MMSE and the Pfeiffer’s Mental State Questionnaire
(PMSQ) in 260 free living mentally healthy older subjects. Subjects with adequate scores
in the MMSE (>28 pts) had lower intake of SFA, MUFA and cholesterol (Ortega et al.,
1997). This study included macro and micro nutrients assessment, but did not include
TFA intake.
The Italian Longitudinal Study on Aging examined the relationship between
macronutrients and cognitive impairment in a population-based sample of 278 subjects
aged 65 to 84. MMES, selective attention (Digit Cancellation Test) and episodic memory
(Babcock Story Recall Test) were used to assess cognitive status, while a semiquantitative food frequency questionnaire was used to evaluate macronutrient energy
intakes. Cross-sectional results pointed toward an inverse relationship between MUFA,
PUFA and cognitive decline (Solfrizzi et al., 2006). In this same study, a significant
inverse association between MUFA intakes and selective attention was highlighted
(Solfrizzi et al., 1999).
Contrasting results were found by van de Rest et al (2008) in a similar study
conducted in the United States. This study used a battery of tests including MMSE,
memory tests, language test and perceptual speed and attention in 1025 elder men. Cross-
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sectional analysis found no association between fatty fish or PUFA (van de Rest et al.,
2008).
Conflicting results were also found in studies of the association between plasma
concentration of omega-3 PUFA and prevalence and incidence of cognitive impairment
and dementia. Data from the Canadian Study of Health and Aging found no significant
difference in omega-3 PUFA plasma concentrations between controls and both prevalent
cases of cognitive impairment and dementia (Laurin, Verreault, Linsay, Dewailly &
Holub, 2003). This is consistent with a population-based Italian study of 191 elders
where no association was found between plasma phospholipid fatty acids and results
from the MMSE (Manzato et al., 2003).
Results from Conquer et al (2000), point in the opposite direction, suggesting that
low levels of n-3 fatty acids in the plasma may be a risk factor for cognitive impairment,
Alzheimer’s disease and/or dementia. However, statistical analyses from this study do not
consider confounding factors such as age and educational level. Another limitation is that
no dietary intakes or histories were done; therefore, it is unclear if the subjects presently
consume, or consumed in the past, diets that were lower in PUFAs.
Older adults with mild to severe cognitive impairment or any form of dementia
may alter their diet as a result of their disease. In addition, dietary intakes can be altered
by cognitive decline and impairment. Longitudinal studies can provide data to identify
these observations.
A three-year long prospective study examined the effects of dietary fatty acids on
cognitive decline in 482 women. Dietary intake was assessed with Food Frequency
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Questionnaire (FFQ) while cognitive status was evaluated with various tests including
Consortium to Establish a Registry for Alzheimer’s disease (CERAD) word list learning,
constructions and word fluency tests. Results showed no association between cognitive
decline and intake of saturated fat, trans fat or dietary cholesterol intake. MUFA intake
was associated with lower cognitive decline, particularly in the visual and memory
domains (Naqvi et al., 2011).
The Chicago Health and Aging Project followed 3718 subjects over 65 years old
for six years. Dietary intake was evaluated with a 139-item FFQ. Cognitive change was
measured at 3 and 6 years follow-ups with the East Boston Memory Test (EBT) of
immediate and delayed recall and the MMSE and the Symbol Digit Modalities test for
perceptual-motor speed (SDMT). Results suggest that a diet high in saturated and trans
fats may be associated with cognitive decline in older adults (Morris, Evans, Tangney,
Bienias & Wilson, 2004). Dietary fish intake was inversely associated with cognitive
decline, while there were no consistent associations with n-3 PUFAS (Morris et al.,
2005).
At the moment, the longest longitudinal study of the relationship between
cognitive health and diet, called the Cardiovascular Risk Factors, Aging and Dementia
(CAIDE) was conducted in Finland. A population of 1449 people aged 65 to 80 years
was followed for a total average of 21 years. A FFQ was used for dietary assessment. To
determine the presence or absence of mild cognitive impairment, evaluations of cognitive
and executive global functions, memory, and psychomotor skills were conducted.
Abundant saturated fat at midlife was associated with poorer global cognitive function
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and prospective memory after adjusting for confounders. In contrast, high intake of
PUFA was associated with better semantic memory. Furthermore, frequent fish
consumption was associated with better global cognitive function and semantic memory.
Further, higher PUFA–SFA ratio was associated with better psychomotor speed and
executive function (Eskelinen et al., 2008).

2.5 Dietary Patterns and Cognitive Decline
The traditional Mediterranean diet pattern is characterized by an abundance of
plant foods (cereals, bread, fruits, nuts, potatoes); non-processed locally grown foods;
locally grown fresh fruit as dessert; sweets eaten a few times a week; olive oil as the main
source of fats; daily consumption of dairy products, low to moderate amounts of fish and
poultry; low consumption of red meats, up to four eggs per week, and low to moderate
consumption of red wine, usually with meals (Willet et al., 1995). This dietary pattern has
been associated with a reduced risk of total mortality, cardiovascular diseases and cancer
(de Logeril & Salen, 2006; Sofi, Cesari, Abbate, Gensini & Casini, 2008; Willet et al.,
1995). The Mediterranean diet has also been associated protection against cognitive
decline in older adults, because it combines foods and nutrients that may have potentially
protective effects against cognitive dysfunction: fish, MUFA, antioxidants, folates,
cobalamine (vitamin B12) and red wine (Feart et al., 2009).
A number of studies have looked into the role that specific foods and nutrients of
this diet may have on the protective role against dementia of cognitive decline. These,
studies on isolated nutrients or food have conflicted results (Feart, Samieri & Barberger-
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Gateau, 2010), perhaps because the analyses of single nutrients or foods ignore important
interactions among components. People do not eat nutrients or just one type of food; they
have dietary patterns that are better suited to the dietary patterns analysis approach.
Scarmeas et al., (2009) studies the association between the Mediterranean diet and
Mild Cognitive Impairment (MCI), which identifies people who are in the transition
between normal aging and dementia or Alzheimer’s disease. Results from this
longitudinal multiethnic community study in New York (n=1393) suggest an association
between the Mediterranean diet and reduced risk of developing MCI, and a reduced risk
of MCI conversion to Alzheimer’s disease (Scarmeas et al., 2009). In this study sample,
the association of a subsample of 262 of incident cases of Alzheimer’s disease was also
investigated. Higher adherence to the Mediterranean diet was found to be associated with
a reduction of Alzheimer’s disease risk (Scarmeas, Stern, Tang, Mayeux & Luchsinger,
2006).
A prospective cohort study of 1410 adults over 65 years old conducted in
Bordeaux, France, evaluated adherence to the Mediterranean diet while assessing
cognitive health with four neuropsychological tests, including the MMSE (Feart et al.,
2009). Results showed that a higher adherence to this type of diet was positively
associated with fewer MMSE errors; however, this was not consistent with the cognitive
tests (Feart et al., 2009).
Nurk et al., 2007 examined fish and seafood consumption and cognitive
performance in the Hordaland Health Study in Norway. This study has a sample of 2,031
subjects ages 70 to 74 and used six different cognitive tests, including the MMSE. There
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was a positive dose-dependent association between fatty fish intake and cognition (Nurk
et al., 2007).
The Zutphen Elderly Study (The Netherlands) followed 210 subjects ages 70-89
during for five years. Dietary information was collected using the cross-check dietary
history method and MMSE was used for cognitive assessment. Fish consumption was
associated with decreased cognitive decline. Furthermore, combined intake on EPA and
DHA seemed to have a dose-dependent relation with reduced cognitive decline (van
Gelder et al., 2007).
Since the evidence remains inconclusive, the Mediterranean diet pattern and fish
intake, does not fully explain the better health of persons with this kind of dietary pattern,
although it may contribute to it. Moreover, this diet may indirectly represent an indicator
of a complex set of favorable lifestyle factors that altogether may contribute to better
health outcomes.

2.6 Supplement Use and Cognitive Health
Nutrient supplementation of both micronutrients and macronutrients are widely
used to improve diet quality and contribute to the maintenance of good health across the
life span. Assessments of the association of supplement use and cognitive health has been
limited by the finding that those who seem to have healthier lifestyles are also more
likely to use supplements (Conner, Kirk, Cade & Barrett, 2001).
In a nested case-control study, fish oil users were matched with nonusers, and
cognitive function was related to erythrocyte n-3 fatty acid composition. Results
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suggested that food supplement use and erythrocyte n-3 content are associated with better
cognitive aging (Whalley et al., 2008)
A comprehensive literature revealed only two randomized clinical trials resulting
in publication on PUFA supplementation on elderly subjects. The first study was
conducted by Terano et al 1999 in Japan. The Older People and n-3 Long-Chain
Polyunsaturated Fatty Acids Study (OPALS) study conducted in the United Kingdom
recruited 867 participants ages 70–79 years; at baseline, all were free of dementia and
diabetes, had a minimum of 25 out of 30 in the MMSE score and did not report daily fish
oil supplement consumption. Subjects were randomly assigned into a double-blind
controlled trial of daily capsules providing EPA, DHA or olive oil. A standardized
battery of cognitive tests was used, including but not limited to subjective memory
assessment, tests of prospective memory, story recall (immediate and delayed), verbal
fluency, location memory (immediate and delayed) and symbol-letter substitution. After
24 months, results supported the theory that high levels of fish consumption, especially
fatty fish, were associated with better cognitive function in later life (Dangour et al.,
2009).
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CHAPTER THREE
MATERIALS AND METHODS

3.1 Study design
This is a cross-sectional secondary data analysis from the Costa Rican Longevity and
Healthy Aging Study (CRELES, or Costa Rica Estudio de Longevidad y Envejecimiento
Saludable) public use data files (Rosero-Bixby, Fernández, & Dow, 2005a). All terms
and conditions from the Inter-University Consortium for Political and Social Research
(ICPSR) for the use of this data base have been met (see Appendix A). CRELES is a
nationally representative longitudinal survey of health and socioeconomic indicators of
Costa Rican residents ages 60 and over in 2005. It was the first nationally representative
survey to investigate older adult health levels in the country.
The principal investigator is Luis Rosero-Bixby; co-principal investigators area Xinia
Fernández (University of Costa Rica) and William H. Dow (University of California,
Berkeley). The study design and data collection were conducted by the University of
Costa Rica's Centro Centroamericano de Población (CCP) in collaboration with the
Instituto de Investigaciones en Salud (INISA), with the support of the Wellcome Trust
(grant 072406). Additional collaborating public entities include the Costa Rican Office of
Social Security (CCSS) and the National Council of Senior Citizens (CONAPAM).
This study was approved by the Ethical Science Committee of the University of Costa
Rica in its March 17, 2004, session (reference: VI-763-CEC-23 -04), research project
number 828-A2 -825 (see Appendix B). All of the databases of the study are anonymous
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(i.e., names and identifiers have been removed) to avoid breeches in the privacy of the
participants. For secondary data analysis, The Clemson University Office of Research
Compliance determined that this thesis does not involve human subjects as defined in the
federal regulations governing the protection of human subjects in research [45 CRF
46.1029(f)] (see Appendix C). Therefore, it was not subject to the Institutional Review
Board review.

3.2 Sampling
The sample was drawn from Costa Rican residents in the 2000 population census
who were born in 1945 or before, with an over-sample of the oldest old (ages 95 and
over), including an in-depth longitudinal survey in a subsample of 3,000 of these
individuals. The inclusion criteria are residence in Costa Rica, regardless of nationality,
and a birth date prior to 1946 (i.e., 60 years or older at the time of the first interview).
A random selection was made from the database of the Census of Population of
2000 (Insituto Nacional de Estadística y Censo, 2000). Sampling was stratified by 5-year
age groups, varying from 1% of the population born from 1941 to 1945 up to 100% of the
population born before 1905 (over 95 years old at the time of the first data collection
round). A subsampling of 60 of the 102 health areas in Costa Rica covering 59% of the
national territory, was selected (see Figure 1), According to the 2000 Census (INEC,
2000) this subsample of nearly 5,000 people met the inclusion criteria, making it possible
to locate and interview 2,827 individuals (n=1,329 men, n=1,498 women). The noanswer rates can be categorized into several groups: 19% of people were deceased by
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date of contact, 18% of people could not be located (mostly due to inaccurate addresses),
2% had changed residence, and 4% declined to be interviewed. Among those who were
interviewed, 95% gave a blood sample, 92% gave a urine sample.

Figure 3.1 Map of the interviewed subjects from the selected Health Areas
(Rosero-Bixby, Fernández & Dow, 2005b).

3.2 Data Collection
Baseline household interviews were conducted between November 2004 and
September 2006, with two-year follow-up interviews. CRELES public use data files
contain information on a broad range of topics, including self-reported physical health,
psychological health, living conditions, health behaviors, healthcare utilization, social
support, and socioeconomic status.
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A field team of five interviewers, two phlebotomists, and a field supervisor collected
the information and the blood and urine specimens using a continuous fieldwork design
over a period of nearly 2 years. All data and specimens in the study were collected at the
participants’ homes, usually during two visits, using personal digital assistants (PDAs),
also known as palm computers, with software applications developed by CCP for this
study. To ensure a good level of dependability, the PDA data collection was tested during
the pilot study by registering answers in both paper and pencil and PDA (HidalgoCespedes, Rosero-Bixby, & Antich-Moreno, 2007). The PDA software did not allow
registering inconsistent data, entering data outside of the range, and/or skipping the
sequence of questions. Once the interview was completed, the data were ready for
analysis, without the possibility of transcription errors (Hidalgo-Cespedes et al., 2007).
During the first visit, participants provided informed consent and answered a 90minute long questionnaire. During the second visit, typically conducted early in the
morning the day after the initial interview, urine samples, blood samples and
anthropometric measures were collected by trained personnel.

3.3.1 Diet.
A semi-quantitative questionnaire based on Willet et al.’s (1985) questionnaire,
was developed specifically for Costa Rican populations (Campos et al., 1991). This
questionnaire asks for the average consumption during the previous year (prior to the day
of the survey). The nine options to categorize consumption frequency range from ―never
or less than once a month‖ to ―6 or more times a day.‖ Information about vitamins and
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nutritional supplements as well as most frequently used type of fat or oil for cooking
(shortening, margarine, etc.) at home was also requested. For each individual, the intake
of energy and other nutrients was calculated by multiplying the frequency of
consumption of each food by the nutritional content of the respective portion. Using
stepwise regression, CRELES researchers reduced the original 147-item FFQ to an
abbreviated version, identifying 27 tracer foods in addition to the type of oil used for
cooking. This step was to done to gather information on the nutrients of greater interest as
well as reduce the interview time (Rosero-Bixby et al., 2005b)

3.3.2 Cognitive disability.
Cognitive disability was assessed using a 15-item scale (Cronbach’s alpha = 0.72)
adaptation of the Mini-Mental State Examination (MMSE) (Folstein, Folstein, &
McHugh, 1975; Quiroga, Albala, & Klaasen, 2004; Rosero-Bixby & Dow, 2009).
Participants who answered fewer than 75% of the 15 items correctly were considered to
be ―cognitively impaired.‖

3.3.3. Lipid profile.
Clinical laboratories involved in the blood analyses were certified by a national
reference center of clinical chemistry that is a part of the Ministry of Health. These
laboratories conduct internal reliability tests as part of their quality control procedures. In
addition, blinded reliability analyses were conducted by the CRELES research team:
Batches of 20 to 40 random samples were reanalyzed for each biomarker in a control
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laboratory. For all lipid analyses, correlations above 0.9 were found between laboratories.
Systematic differences were found for HDL and triacylglyceride values from two clinical
laboratories. In response, these values were adjusted with equations estimated by
regression using the validation batches (Mendez-Chacon, Rosero-Bixby, FernandezRojas, & Barrantes-Jimenez, 2007).

3.4 Analysis
Collected data from CRELES are available to the public at the ICPSR, the
National Archive of Computerized Data on Aging, and the National Institute of Aging’s
website (ICPSR, 2010). Data are available for SPSS and SAS software and are divided
into 10 data sets: anthropometry and mobility, biomarkers, diet, elderly people,
household members, insurance, medications, non-resident children, pensions, and
recoded variables. In addition to these files, this website provides questionnaire sets;
information about weighing, sampling, and data collection procedures; and a codebook.
The codebook includes variable names, variable types, missing values, ranges, and labels
(e.i., 1= yes, 0 = no).
Statistical analyses were conducted using IBM SPSS Statistics version 19 (IBM
Corporation, Somers, NY, 2010). The first step was to identify which variables will be
used from the nearly one nine hundred variables recorded. All data sets were revised
once variables were identified; unneeded variables were dropped, and all necessary
variables from different data sets were merged into a new file. In addition to variables
related to the research questions, variables needed for data identification and analysis
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(e.i., identification, health areas, non-response weight, and age) were included in the
new database. To confirm to normality, tests of skew and kurtosis were conducted.
Significance tests for skew and kurtosis were not used because, in large sample sizes,
they are likely to be significant even when skew and kurtosis are not significantly
different from normal (Field, 2010).
To obtain nationally representative data, all descriptive statistical analyses were
conducted while weighing for the variable ―ponderator‖ (Rosero-Bixby, Fernández, &
Dow, 2005c). This sampling weight was used to correct for two factors: (1)
oversampling of the oldest-old individual and (2) the higher non-response rate among
younger men with high SES who are living in urban settings. The results provided data
that replicate the structure by sex, age, urban residence, and education of the population
of Costa Ricans born in 1945 or before and still living in 2005.
General characteristics between cognitively disabled and non-cognitively disabled
subjects were explored using descriptive statistics. T-test statistics were used to assess
significant differences between means for age, years of schooling, and income. Chi
square tests were conducted to compare categorical differences such as sex, residence,
and previously diagnosed medical conditions (hypertension, diabetes, etc). When
looking at the serum lipid profiles, data from participants using lipid-lowering
medication were removed to avoid bias.
The effects on cognitive health were examined using two cognitive health
variables: cognitive scale and cognitive disability. The cognitive scale was standardized
to scores between 0 and 100. The cognitive disability variable was dichotomized: 1 being

50

the absence of cognitive disability and 0 being the presence of cognitive disability. The
cutoff point was inaccurately responding to fewer than 12 out of 15 (75%) of the items on
the MMSE. A value of ―0‖ was assigned whenever the participant needed a proxy for the
interview.
In addition, new variables needed to be created using information from the data
set. In the CRELES data set, fatty acid intake is reported in grams per day. When using
this variable to compare energy intake, nutrients were adjusted by energy intake (Willet,
1998). Fat intake was also intake examined as total energy and grams per day. Saturated,
monounsaturated, polyunsaturated, and trans fatty acid variables reported in grams per
day, were transformed into a calorie percentage using the following formula:

Percentage of calories per dayi = [(Fati g/day * 9 kcal/g)* total calorie intakei]* 100

For the linear regression models, variables were entered according to the potential
influence each variable may have on the dependent variable according to findings from
previous research. All variables found to be not significant (p> 0.05) were removed from
the model. This model was controlled for age, caloric intake and lipid medication. In
addition to the regression analysis, descriptive statistics (mean, standard deviation, and
correlation), 95% confidence intervals, and an analysis of variance (ANOVA) were
completed. A logic regression model was created to assess the relationship between these
variables and the presence or absence of cognitive impairment.
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CHAPTER FOUR
ASSOCIATION BETWEEN NUTRTION, HEALTH INDICATORS AND COGNITIVE
FUNCTION IN COSTA RICAN OLDER ADULTS
In Preparation for Journal of Nutrition and Aging

4.1 Introduction
Older adults are among the fastest-growing segment of the world’s population.
The number and proportion of this population is increasing in both developing and
developed countries. In five years, the number of people aged 65 or older will outnumber
children under the age of five (World Health Organization, National Institute of Aging &
National Institute of Health, 2011). In Costa Rica, life expectancy is comparable to
developed countries such as the United States and Western European countries. Of added
importance to this comparison, is the fact that the Costa Rican gross national product
(GNP) is a small fraction of the GNP for American or Western European countries
(United Nations, 2009). Increases in longevity and the proportion of people over the age
of 60 years are often regarded as a challenge to health systems as longer lives are
commonly associated with an increased prevalence of disease (World Health
Organization, 2000). The loss of cognitive capacity is one of the most important factors
affecting the quality of life of older adults and their families. In addition, it is one of the
main reasons that people are admitted into nursing homes (Gaugler, Duval, Anderson, &
Kane, 2007). The causes of cognitive decline remain uncertain; however, it has been
linked to cardiovascular disease and risk factors such as diabetes mellitus and high blood
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pressure (Naqvi et al., 2011). Dietary fatty acids play an important role in cardiovascular
disease; thus, it is plausible that they could have a role in cognitive deterioration as well
(Hunter, Zhang & Kris-Etherton, 2009). Fatty acids could be involved through several
mechanisms, including atherosclerosis, thrombosis, and inflammation (Kalmijn, 2000).
Increasing interest has emerged in the hypothesis that the consumption of fish,
polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA) and docohexanoic acid
DHA could play a protective role against cognitive decline. Several studies have
suggested that an increase of saturated fats could have negative effects on cognitive
health (Kalmijn, Feskens, Launer & Kromhout, 1997; Morris et al., 2003), while PUFA
and MUFA may have a protective effect (Capurso et al., 2003; Solfrizzi et al., 1999).
Still relatively few findings exist about the differentials and determinants of aging
and longevity. Although research on the impact of diet on aging and longevity has been
conducted in developed nations, little is known about the populations from developing
countries. The purpose of this current research is to examine the association between fatty
acid intake, lipid profile, and cognitive health in Costa Rican elders. We had the
opportunity to examine these issues using data from the Costa Rican Longevity and
Healthy Aging Study (CRELES, or Costa Rica Estudio de Longevidad y Envejecimiento
Saludable) public use data files (Rosero-Bixby, Fernández & Dow, 2005a).

4.2 Materials and Methods
This is a cross-sectional secondary data analysis from CRELES’s public use data
files (Rosero-Bixby et al., 2005a). CRELES is a nationally representative longitudinal

55

survey of health and socioeconomic indicators of Costa Rican residents ages 60 and over
in 2005. The study design and data collection were conducted by the University of Costa
Rica's Centro Centroamericano de Población (CCP) in collaboration with the Instituto de
Investigaciones en Salud (INISA), with the support of the Wellcome Trust (grant
072406). Additional collaborating public entities included the Costa Rican Office of
Social Security (CCSS) and the National Council of Senior Citizens (CONAPAM). This
study was approved by the Ethical Science Committee of the University of Costa Rica.

4.2.1 Study population
The sample was drawn from Costa Rican residents in the 2000 population census
who were born in 1945 or before, with an over-sample of the oldest-old (ages 95 and
over). The inclusion criteria required living in Costa Rica, regardless of nationality, and
to birth date before 1946, meaning participants had to be 60 years or older at the time of
the first interview. A random selection was made from the database of the Census of
Population of 2000 (Insituto Nacional de Estadística y Censo, 2000). Sampling was
stratified by five-year age groups, varying from 1% of the population born in 1941-1945
up to 100% of the population born before 1905 (over 95 years old at the time of the first
data collection round). The no-answer rates can be classified as following: 19% of people
deceased by date of contact, 18% of people could not be located (mostly due to the
inaccurate addresses), 2% had changed residence and 4% declined to be interviewed.
From those who were interviewed, 95% gave a blood sample, 92% gave a urine sample
and almost 25% of all subjects needed a proxy (usually a close relative).
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4.2.3 Data collection
Baseline household interviews were conducted between November 2004 and
September 2006, with two-year follow-up interviews. A field team of five interviewers,
two phlebotomists and a field supervisor collected the information and the blood and
urine specimens using a continuous fieldwork design over a period of nearly 2 years. All
data and specimens in the study were collected at the participants' homes, usually during
two visits. They were collected using personal digital assistants (PDAs), also known as
palm computers, with software applications developed by CCP for this study. During the
first visit, participants provided informed consent and answered a 90 minute long
questionnaire. During a second visit, which was typically held early in the morning the
day after the initial inerview, urine samples, blood samples and anthropometric measures
were collected by trained personnel (Rosero-Bixby, Fernández & Dow, 2005b).
Information on the participants’ diet was collected using a previously validated
Food Frequency Questionnaire (FFQ) (Campos et al., 1991). This is a semi-quantitative
questionnaire based the Willett et al’s (1984) questionnaire, developed specifically for
Costa Rican populations (Campos et al., 1991). The questionnaire asks for the average
consumption during the previous year (prior to the day of the survey). The nine options to
categorize consumption frequency are a range from "never‖ or ―less than once a month"
up to "6 or more times a day‖. Information about vitamins and nutritional supplements as
well as type of fat or oil used most frequently for cooking (shortening, margarine, etc.) at
home was also requested. For each individual, energy and nutrient intake were calculated
by multiplying the frequency of consumption of each food by the nutritional content of
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the respective portion. Using stepwise regression, CRELES researchers reduced the
original FFQ to an abbreviated version, identifying 27 tracer foods in addition to the type
of oil used for cooking. This process resulted in information on the nutrients of greater
interest and the ability to reduce the interview time.
Cognitive disability was assessed with a 15-item scale (Cronbach alpha = 0.72)
adaptation of the Mini-Mental State Examination (MMSE) (Folstein, Folstein &
McHugh, 1975; Quiroga, Albala, & Klaasen, 2004; Rosero-Bixby & Dow, 2009).
Participants who answered fewer than 75% of the 15 items correctly were considered to
be ―cognitively impaired.‖
Clinical laboratories involved in the blood analyses were certified by a national
reference center of clinical chemistry that is a part of the Ministry of Health. These
laboratories conduct internal reliability tests as part of their quality control procedures. In
addition, blinded reliability analyses were conducted by the CRELES research team. For
this, batches of 20 to 40 random samples were reanalyzed for each biomarker in a control
laboratory. For all lipid analyses, correlations above 0.9 were found between laboratories.
Systematic differences were found for HDL and triacylglyceride values from two clinical
laboratories. In response, these values were adjusted with equations estimated by
regression using the validation batches (Mendez-Chacon, Rosero-Bixby, FernandezRojas & Barrantes-Jimenez, 2007).
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4.2.4 Statistical Data
Statistical analysis was conducted using IBM SPSS Statistics version 19 (IBM,
2010). The effects on cognitive health were examined on two cognitive health variables:
cognitive scale and cognitive impairment. The cognitive scale was standardized to
scores between 0 and 100. The cognitive impairment variable was dichotomized, with 1
being the absence of cognitive impairment and 0 being the presence of cognitive
impairment. The cutoff point was inaccurately responding to fewer than 12 out of 15
(75%) of the items on the MMSE. A value of ―0‖ was assigned whenever the subject
needed a proxy for the interview.
To obtain nationally representative data, all descriptive statistical analyses were
conducted weighting for the variable ―ponderator‖ (Rosero-Bixby, Fernández & Dow,
2005c). This sampling weight will correct for two factors: (1) oversampling of the
oldest-old individuals and (2) the higher non-response rate among younger men with
high SES and who are living in urban settings. General characteristics between
cognitively disabled and non-cognitively disabled participants were explored using
descriptive statistics. T-test statistics were used to assess significant differences between
means for age, years of schooling and income. Chi square tests were conducted to
compare categorical differences such as sex, residence and previously medically
diagnosed conditions (hypertension, diabetes, etc). In terms of the lipid profiles, data
from subjects using lipid lowering medication was removed to avoid bias.
For the regression models, variables were entered according to the potential
influence they may have over the dependent variable according to findings from
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previous research. All variables found not to be significant (p> 0.05) were removed from
the model. The model was controlled for age, caloric intake, lipid medication, and
stroke. In addition to the regression analysis, descriptive statistics, 95% confidence
intervals, and analysis of variance (ANOVA) were completed.

4.3 Results
As shown in Table 4.1, the study population has a mean age of 70.5 years. Highly
significant differences (p<0.01) were found between mean ages from cognitively disabled
and non-cognitively disabled adults. The cognitively disabled population included a
greater percentage of women (p<0.05). No relevant differences were found in living
settings. For all cases, more than half of the participants were living within the Great
Metropolitan Area (GMA), which includes the city of San Jose and surrounding
metropolitan areas (406km2). Most of the population reported some years of elementary
education. Noteworthy differences were found in years of education, where the
cognitively disabled population reported a smaller average of school years (p<0.01).
Important differences were also found in monthly income; cognitively disabled
participants presented a low mean monthly income in comparison to the non-cognitively
disabled. In addition, the majority of the cognitively disabled population was found to
have an income below the poverty line (less than US$100/month) (p<0.01), whereas for
the general study population and the non-cognitively disabled one third fell below the
poverty line.

60

Table 4.1 General Characteristics of the CRELES Study Participantsa
Characteristics

CRELES

Cognitive Disability

p-

Yes

No

(n=314)

(n=2505)

47.5

41.1

48.3

.017*

70.5 (±8.1)

79.1 (±9.5)

69.37 (±7.2)

.000**

60-69 (%)

53.5

17.8

58.3

70-79 (%)

32.0

33.5

31.3

15

48.7

10.4

53.0

51.1

53.2

5.2 (±4.2)

2.8 (±3.3)

5.5 (±4.2)

No formal education (%)

13.7

33.7

11.2

Elementary (%)

64.8

59.6

65.4

11.9

3.5

13.0

9.6

3.2

10.4

458.8

186.8

493.0

(±1332.9)

(±346.6)

(±1394.3)

<US$100/month (%)

39.0

56.3

36.9

US$100 - US$399/month (%)

41.8

33.8

36.8

>$399/month (%)

19.2

9.9

26.3

Men (%)
Age (years)

≥80 (%)
Living in GMA (%)
Education (years)

(n=2827)

value

.473
.000**

(1st- 6th grade)
High school education (%)
th

th

(7 -11 grade)
Higher education (%)
Monthly income (US$)

a

.000**

Missing values weighted

* p<0.05

**p<0.01

General health information evidenced a more positive health profile for noncognitively disabled participants (Table 4.2). Statistical significance differences were
found in the ratio of cognitively disabled elders who had been medically diagnosed with
stroke and heart attack (p<0.01), and other heart conditions (p<0.05). A higher
percentage of elders without cognitive disability reported a diagnosis of dyslipidemia
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(p<0.01). Metabolic syndrome and BMI were also found to be higher among the noncognitively impaired (p<0.001); however, these variables are not medical diagnoses but
outcomes calculated from collected biomarkers and anthropometric measurements.

Table 4.2 General Health Characteristics of the CRELES Study Participantsa

Characteristics

CRELES
(n=2827)

Cognitive Disability
Yes

No

(n=314)

(n=2505)

pvalue

Diagnosed conditions
Hypertension (%)

48.2

51.2

47.9

.214

High Cholesterol (%)

39.1

29.1

40.3

.000**

Diabetes (%)

20.8

21.8

20.6

.566

Stroke (%)

3.8

15.9

2.3

.000**

Heart attack (%)

4.6

8.1

4.1

.009**

Other heart conditions (%)

12.0

17.0

11.4

.013*

Metabolic syndrome (%)

47.1

39.0

48.0

.006**

Mean Weight (lbs)

145.5

129.4

147.2

.000**

(±30.4)

(±31.1)

(±29.9)

26.9 (±5.2)

24.8 (±5.4)

27.1 (±5.2)

Mean BMI (kg/m2)
a

.000**

Missing values weighted

*p<0.05

**p<0.01

Differences in BMI are also reflected in all four BMI categories (WHO, 2002).
As shown in Figure 4.1, the percentage of cognitively disabled older adults classified as
underweight and normal is significantly higher than non-cognitively disabled (p<0.010).
Furthermore, the percentage of non-cognitively disabled older adults classified as
overweight and obese is significantly larger than the cognitive disabled (p<0.010).
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45
40
35

Kg/m2

30
25
20
15
10
5

12.3 2.2

36.2 27.5

33.3

41

18.2 27.1

0

Underweight**

Normal**
Overweight**
BMI Classification

<75% MMSE (n=314)

* p<0.05

Obese**

>75% MMSE (n=2505)

** p<0.01
Figure 4.1 BMI classification and cognitive disability

When comparing energy and macronutrient intake between those considered
cognitively disabled (<75% right answers in the MMSE) and those who are not (Table
4.3), energy and MUFA were greater in the latter group (p<0.01 and p<0.05
respectively). TFA intake was higher in participants with cognitive disability (p<0.01).
No significant differences were found in protein and dietary cholesterol intake between
groups.
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Table 4.3 Dietary Intake in Relation to Cognitive Disabilityab
Nutrient

Cognitive Disability (mean ±SD)

t-test

Yes (n=314)

No (n=2505)

1983.84 ±718.13

2178.47 ±730.72

70.55 ±9.32

69.96 ±9.61

.284

308.43 ±29.56

307.82 ±35.63

.738

74.09 ±10.64

74.70 ±14.23

.369

253.93 ±104.10

246.01 ±110.88

.230

SFA (g)

27.67 ±7.17

26.89 ±7.48

.080

MUFA (g)

24.16 ±7.79

25.35 ±11.01

.016*

PUFA (g)

18.22 ±5.38

18.62 ±5.32

.207

n-6 PUFA (g)

16.23 ±4.98

16.64 ±4.96

.203

n-3 PUFA (g)

1.92 ±.61

1.95 ±.61

.441

TFA (g)

3.16 ±.89

2.97 ±.95

.001**

Energy (kcal)
Protein (g)
Carbohydrates (g)
Total Fat (g)
Dietary Cholesterol (mg)

a

Missing values weighted

b

Nutrients adjusted for energy intake.

* p<0.05

.000**

** p<0.01

Figure 4.2 compares differences in energy and macronutrient intake between
cognitively disabled and non-cognitively disabled participants. Energy, total fat, and
MUFA intake were significantly greater in non- cognitively disable subjects (p<0.01). No
significant differences were found in SFA, TFA and PUFA intake.
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40
35

% Energy Intake

30
25
20
15
10
5
0
Total Fat*

SFA

MUFA**

PUFA

PUFA-n6

PUFA-n3

TFA

Nutrient
<75% MMSE (n=638)

* p<0.05

>75% MMSE (n=2178)

** p<0.01
Figure 4.2 Fat intakes and cognitive disability

The lipid profile from cognitively disabled individuals was compared to the lipid
profile of that of non-cognitively disabled. Non-cognitively disabled individuals were
grouped according to their use of lipid medications. Only one cognitively disabled elder
reported using lipid medication. (Figure 4.3).
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300.0

250.0

mg/dL

200.0

150.0

100.0

50.0
45.0

44.2

48.2

128.5

138.1

135.6

148.5

166.7

149.7

202.2

215.2

0.0
HDL

LDL**

TAG**
Serum Lipids

<75% MMSE (n=235)

TC = Total Cholesterol
* p<0.05

>75% MMSE No Med (n=1777)

>75% MMSE Lip Med (n=19)

TAG = Triacylglyderides

** p<0.01
Figure 4.3 Serum lipid profile and cognitive disability
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TC**

213.6

Contrary to our expectations, the lipid profile of non-cognitively impaired
participants who were not taking lipid medications was more detrimental; total
cholesterol, LDL, and triglycerides were significantly higher in this population (p<0.01)
than their cognitively impaired counter parts. No noteworthy differences were found in
HDL. No significant differences were found between those who reported taking lipid
medications and those who did not.
The linear regression analysis was done using the scale of cognitive performance
as the outcome variables, adjusting for age and lipid medication (Table 4.4). This scale
was based on MMSE results, with 100 representing a good outcome and 0 an undesired
outcome. Participants who required a proxy during the interview were automatically
assigned a score of 0. The model chosen presented an R2=0.299 and a significance of
0.000, meaning 29% of the variance can be explained by this model. A positive
association was found with total fat intake (β coefficient = 3.9, p<0.01), n-6 PUFA (β
coefficient = 1.336, p<0.05) and n-3 PUFA (β coefficient = .221 p<0.05). In contrast,
PUFA, MUFA, SFA and TFA were found to be negatively associated (p<0.01) with
MMSE score. Total serum cholesterol was negatively associated with cognitive scale
performance and n-6 PUFA (β coefficient = -1.754, p<0.01), while HDL, LDL, and
triacylglyceride (TAG) were found to bepositively associated with a better performance
on the MMSE (p<0.01).
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Table 4.4 Linear regression analysis of dietary fat and intake and serum lipids as
predictors of MMSE score.
Linear Regression Model (R2 = .299 p<0.001)
Variables

β Coefficient

95% CI
Lower

Upper

p-value

Total Fat (%)

3.944

3.485

15.334

.002**

PUFA (%)

-3.389

-26.655

-5.157

.004**

MUFA (%)

-2.623

-15.180

-3.298

.002**

SFA (%)

-2.505

-15.417

-3.341

.002**

Total Cholesterol (mg/dL)

-1.754

-.724

-.176

.001**

LDL (mg/dL)

1.564

.189

.737

.001**

n-6 PUFA (%)

1.336

-.003

13.455

.050

HDL (mg/dL)

.486

.162

.678

.001**

TFA (%)

-.471

-19.210

-5.761

.000**

TAG(mg/dL)

.461

.044

.155

.000**

n-3 PUFA (%)

.221

1.780

16.449

.015*

TC = Total Cholesterol
* p<0.05

TAG = Triacylglyderides

** p<0.01

Table 4.5 shows the logistic regression using the absence or presence of cognitive
disability as the outcome variable. Several models were proposed; however, the only
model that showed statistical significance for both the model and variables included total
fat and total cholesterol variables only. Total fat intake presented an odds ratio of .970
(p<0.050). As total fat intake increases, the odds of being cognitively disabled decreases.
In contrast, the total serum cholesterol odds ratio was 1.996 (p<0.010); thus, as serum
cholesterol increases, the chance of cognitive impairment doubles.

68

Table 4.5 Logistic regression correlated of dietary fat intake and serum cholesterol as
predictors of cognitive disability
Logistic Regression Model
(Nagelkerke R2 = .331 p<0.000)

Variables

95% CI

Odds Ratio

Lower

Upper

p-value

Total Fat (%)

.970

.947

.993

.010*

Total Cholesterol (mg/dL)

1.996

1.993

1.998

.001**

* p<0.05

** p<0.01

4.4 Discussion
This study found highly significant differences between cognitively disabled and
non-cognitively disabled older adults. Demographic data showed that adults who scored
less than 75% on the MMSE were younger, had lower income, and had fewer years of
formal education. Important differences were also found in the health profile. Medical
diagnoses of diabetes, stroke, and heart attack were significantly higher among the
cognitively disabled. Non-cognitively disabled adults had a higher rate of medical
diagnosis of dyslipidemia and presented a higher rate of metabolic syndrome according to
study samples and data. Anthropometric data confirmed that cognitively disabled elders
had a lower BMI, lower body weight, and a higher percentage of underweight. Dietary
analysis revealed a lower energy, total fat and MUFA intake in comparison to their
counterparts. Lipid profile of non-cognitively disabled adults exposed significantly higher
levels of LDL, triacylglycerides and total cholesterol. The multiple regression analysis
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suggested a significant (p<.050), yet weak (R2=.299), association between MMSE score
and serum lipid profile and dietary fatty acids (β coefficients <3.9).
Confidence in these findings is strengthened by the following factors. The study
included a large population-based sample, increasing the external validity of the findings.
Diet and cognitive health were assessed using previously validated instruments, that have
been widely used in epidemiological studies. Statistical analyses were controlled for age,
caloric intake, and the use of lipid medications.
The sample of cognitively disabled adults was older and included more women,
which likely stems from the fact that women’s life expectancy is higher than men’s and
the risk of dementia increases sharply with age (World Health Organization, National
Institute of Aging & National Institute of Health, 2011). Cognitively disabled subjects
also reported lower education, suggesting that education may be a protective factor
against cognitive decline. Results from previous research on education and cognitive
decline are controversial. In their literature review, Anstey and Christensen (2000),
implied that most studies usinf the MMSE, which measures crystallized cognition
(vocabulary, general knowledge), found a negative association between education and
cognitive decline; meanwhile studies using fluid measures of cognitive health (pattern
recognition, abstract reasoning, and problem-solving) did not find such associations
(Anstey & Christensen, 2000). Furthermore, results from an 8-year population-based
study concluded that education does not appear to protect against cognitive decline, but
when using the MMSE, less educated individuals may be diagnosed with dementia earlier
(Muniz-Terrera, Matthews, Dening, Huppert & Brayne, 2009). The MMSE is a reliable
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tool for measuring cognitive health; however, it does not assess the type of cognitive
dysfunction. Some conditions such as Alzheimer’s disease, stroke or ischemic dementia
have been linked with lifestyle and health choices (Luchsinder & Mayeux, 2004;
Solfrizzi, Panza & Capurso, 2003) whereas others, such as traumatic brain injury, are not.
This same confounder could apply to the differences found in monthly income,
where almost half of the cognitively impaired adults were found to be living under the
poverty line (<US$100/month). Nevertheless, a robust body of literature supports the
association between socioeconomic status and health association may continue into old
age, although gradients appear smaller at older ages (Crimmins, 2005; Turra & Goldman,
2007).
The prevalence of high cholesterol being greater in the non-cognitively disabled
adults contradicts previous findings. First, dyslipidemia risk increases with age (Grundy
et al., 2011); the older adults in this group are on average younger than the cognitively
disabled participants. Second, high cholesterol is increasingly recognized as a risk factor
for ischemic stroke, silent ischemic white-matter lesions, and vascular dementia
(Kivipeltp et al., 2001; Launer et al., 2000; Skoog et al., 1996). These results can be
attributed to the fact that high cholesterol was self-reported and is frequently undiagnosed
(Grundy et al., 2011); highlighting the limitation of the self-reported nature of the
CRELES information which might be affected by reporting bias.
Cognitively impaired participants presented lower body weight, lower BMI, and
lower metabolic syndrome prevalence. Furthermore, more cognitively impaired adults
were classified as underweight and normal than their counterparts. It is possible that these
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differences can be attributed to changes in diet and lifestyle due to the cognitive
impairment which may interfere with their access to foods, ability to prepare their own
meals and ability to chew and/or swallow certain foods. These assumptions could also
explain the differences found in the dietary analysis and serum lipid profile.
Large population-based studies have examined dietary intake and serum lipid
profile; however, results have been conflicting. In France, Pradignac, Schlienger, Velten,
and Mejean (1995) found a positive relationship between fatty acid intake and the MMSE
in women. A similar study in Spain found that participants with adequate scores on the
MMSE (>28 pts) had lower intake of SFA, MUFA and cholesterol (Ortega et al., 1997).
The Italian Longitudinal Study on Aging indicated an inverse relationship between
MUFA and PUFA, and cognitive decline (Solfrizzi et al., 2006).
Contrasting results were found by van de Rest et al (2008) in a similar study
conducted in the United States. Their study used a battery of tests including MMSE,
memory tests, language test, perceptual speed and attention with 1,025 elderly men. A
Ccross-sectional analysis found no association between fatty fish or PUFA (van de Rest
et al., 2008).
Results from Conquer et al (2000), point in the opposite direction, suggesting that
low levels of n-3 fatty acids in the plasma may be a risk factor for cognitive impairment,
Alzheimer’s disease, and/or dementia. However, statistical analyses from their study do
not consider confounding factors, such as age and educational level. Another limitation is
that no dietary intakes or histories were done; therefore, it is unclear if the participants
consumed at the time or in the past, diets that were lower in PUFAs.
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One important limitation of the current study is the fact that this is cross-sectional
analysis and cannot address cause-and-effect relationships, namely, cognitive disability
affecting dietary intake or dietary intake affecting cognitive disability. The use of FFQs
for dietary assessment include restrictions imposed by a fixed list of foods based on
relatively few diet constituents, reliance on memory, perception of portion sizes, and
interpretation of questions. In addition, there is no data on the validity of the FFQ in
cognitively impaired subjects, and some of the cognitively disabled individuals needed a
proxy for the interview who may or may not have been fully aware of the personal
history (eg. years of formal education) or dietary intake of the participant. Furthermore,
cognition in the elderly is believed to be shaped by long-term exposures (Launer, 2005).
In conclusion, differences in demographic, health, and diet characteristics
emerged between cognitively disabled Costa Rican elders and their counterparts. Dietary
fat intake and serum lipid profile are weakly associated with cognitive outcomes. Further
research, particularly longitudinal studies, are needed to better examine this relationship.
Finally, residual confounding by unknown risk factors is possible, such as a generally
healthier lifestyle of individuals with better dietary intake, which may play an important
role in altering the outcomes. Such possibility cannot be excluded.
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Appendix C
Clemson University Office of Research Compliance (ORC) Review
Dear Catalina and Katherine,

The Clemson University Office of Research Compliance (ORC) has determined that the
project identified above does not involve human subjects as defined in the Federal
regulations governing the protection of human subjects in research [45 CFR 46.102(f)]
and is, therefore, not subject to IRB review.
As per our conversation this afternoon and my review of the website from which the
CRELES data are available
(http://www.icpsr.umich.edu/icpsrweb/NACDA/studies/26681?archive=NACDA&q=crel
es), at this time, this project will not involve either ―intervention or interaction‖ with
living individuals, or the collection or use of ―identifiable private information‖ about
living individuals. Therefore, IRB review is not required.
Please contact this office again if there are any changes to this project that might bring it
under the purview of the IRB. It is the responsibility of the ORC to determine whether
any specific research project falls within the definition of research with human subjects,
as provided by Federal regulations and institutional policy.
Thank you for contacting us to check on whether your project required IRB review and
approval.
Good luck with this project and please feel free to contact me if you have any questions.

Best,

Laura
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